CVS Health (NYSE:CVS) Issues FY 2025 Earnings Guidance

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

CVS Health (NYSE:CVS - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 6.300-6.400 for the period, compared to the consensus EPS estimate of 6.133. The company issued revenue guidance of -.

Analysts Set New Price Targets

Several research analysts have commented on the company. Barclays raised their price objective on CVS Health from $79.00 to $80.00 and gave the company an "overweight" rating in a research report on Friday. Bernstein Bank dropped their price target on shares of CVS Health from $78.00 to $72.00 and set a "market perform" rating for the company in a research note on Wednesday, July 16th. Royal Bank Of Canada boosted their target price on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. UBS Group dropped their target price on shares of CVS Health from $71.00 to $67.00 and set a "neutral" rating for the company in a research report on Tuesday, July 22nd. Finally, Wall Street Zen upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Three investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $75.11.

CVS Health Stock Performance

Shares of NYSE CVS traded up $0.42 during midday trading on Friday, reaching $62.52. 11,376,286 shares of the company traded hands, compared to its average volume of 8,510,677. CVS Health has a 52 week low of $43.56 and a 52 week high of $72.51. The stock has a 50-day moving average price of $64.56 and a 200 day moving average price of $63.85. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.63. The company has a market cap of $79.09 billion, a price-to-earnings ratio of 17.46, a PEG ratio of 0.89 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business had revenue of $98.92 billion for the quarter, compared to analysts' expectations of $94.87 billion. During the same period in the previous year, the business earned $1.83 earnings per share. The company's revenue was up 8.4% on a year-over-year basis. Sell-side analysts anticipate that CVS Health will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.3%. CVS Health's payout ratio is 74.30%.

Insider Activity

In related news, Director Guy P. Sansone bought 1,570 shares of the business's stock in a transaction dated Thursday, June 5th. The shares were bought at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the transaction, the director directly owned 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 1.22% of the stock is owned by company insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.